Pay in 4 interest-free payments of $5.97 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
The other activates three
You might need a replacement
While TMAO has been associated with vascular damage and cardiovascular risk in CKD patients, the evidence is inconsistent
Safety, pharmacokinetics, and pharmacodynamics of the insulin-like growth factor type 1 receptor inhibitor figitumumab (CP-751,871) in combination with paclitaxel and carboplatin
MeAgain's GLP-1 app connects patients with qualified providers who offer personalized guidance throughout the decision-making and treatment process
US$ 28.67
US$ 25.35
US$ 21.95
US$ 26.68
US$ 29.83
US$ 27.98
US$ 20.41
US$ 25.99
